Form 4: Verastem Director Rowinsky Exchanges Stock Options in Company Program

Director Eric K. Rowinsky participated in Verastem's option exchange program, canceling existing stock options with higher exercise prices in exchange for new options.

Summary

• On March 11, 2024, Eric K. Rowinsky, a director of Verastem, Inc., participated in the company's option exchange program.
• Rowinsky canceled several existing stock options with exercise prices greater than $15.00.
• In exchange, Rowinsky received a grant of 12,572 new stock options with an exercise price of $11.44.
• The new options will vest in two equal installments over a two-year period from March 11, 2024, contingent on Rowinsky's continued service as a director or service provider.
• The canceled options had various grant dates and vesting schedules between June 2017 and June 2021.

Sentiment

Score: 6

Explanation: The document describes a routine transaction. It's neither overwhelmingly positive nor negative, but suggests continued alignment between the director and the company.

Positives

• The option exchange program may incentivize the director to remain with the company, as the new options vest over a two-year period.
• The lower exercise price of the new options could make them more valuable to the director.

Future Outlook

The director's continued service is tied to the vesting of the new stock options over the next two years.

Industry Context

Option exchange programs are sometimes used by companies to refresh employee or director incentives, particularly when the stock price has declined significantly since the original options were granted.

Stakeholder Impact

• The option exchange program could potentially align the director's interests with those of shareholders by incentivizing them to increase the company's value.

Key Dates